Difference between revisions of "Test"
From Bioblast
Line 1: | Line 1: | ||
'''Table 8. | '''Table 8. Terms, symbols, and units.''' SI base units are used, except for the liter [L = dm<sup>3</sup>]. SI refers to ref. [[Bureau International des Poids et Mesures 2019 The International System of Units (SI) |[11]]]. | ||
{| class="wikitable" | {| class="wikitable" | ||
Line 7: | Line 7: | ||
! Term !! Link to MitoPedia term !! Symbol !! Unit !! Links and comments | ! Term !! Link to MitoPedia term !! Symbol !! Unit !! Links and comments | ||
|- | |- | ||
| alternative quinol oxidase] || [[ | | alternative quinol oxidase] || [[Alternative oxidase]] || AOX || - || Fig. 1B | ||
|- | |- | ||
| adenosine monophosphate || | | adenosine monophosphate || AMP || AMP || - || 2 ADP ↔ ATP+AMP | ||
|- | |- | ||
| adenosine diphosphate || [[ADP]] || ADP || - || Tab. 1; Fig. 1, 2, 5 | | adenosine diphosphate || [[ADP]] || ADP || - || Tab. 1; Fig. 1, 2, 5 | ||
Line 15: | Line 15: | ||
| adenosine triphosphate || [[ATP]] || ATP || - || Fig. 2, 5 | | adenosine triphosphate || [[ATP]] || ATP || - || Fig. 2, 5 | ||
|- | |- | ||
| adenylates || [[ | | adenylates || [[Adenylates]] || AMP, ADP, ATP || - || Section 2.5.1 | ||
|- | |- | ||
| amount of substance ''X'' || [[ | | amount of substance ''X'' || [[Amount]] || ''n''<sub>''X''</sub> or ''n''(''X'') || [mol] || SI | ||
|- | |- | ||
| ATP yield per O<sub>2</sub> || [[ATP yield]] || ''Y''<sub>P»/O<sub>2</sub></sub> || 1 || P»/O<sub>2</sub> ratio measured in any respiratory state | | ATP yield per O<sub>2</sub> || [[ATP yield]] || ''Y''<sub>P»/O<sub>2</sub></sub> || 1 || P»/O<sub>2</sub> ratio measured in any respiratory state | ||
|- | |- | ||
| catabolic reaction || [[ | | catabolic reaction || [[Respiration]] || k || - || Fig. 1, 3 | ||
|- | |- | ||
| catabolic rate of respiration || [[ | | catabolic rate of respiration || [[Respiration]] || ''J''<sub>kO<sub>2</sub></sub>; ''I''<sub>kO<sub>2</sub></sub> || ''varies'' || Fig. 1, 3; ''see'' flux ''J'' and flow ''I'' | ||
|- | |- | ||
| cell count || [[ | | cell count || [[Count]] || ''N''<sub>ce</sub> || [x] || Tab. 4; Fig. 5; ''see'' number of cells | ||
|- | |- | ||
| cell mass || [[ | | cell mass || [[Mass]] || ''m''<sub>ce</sub> || [kg] || Tab. 5; Fig. 5 | ||
|- | |- | ||
| cell mass, mass per cell || [[ | | cell mass, mass per cell || [[Mass]] || ''M''<sub>''N<sub>ce</sub></sub> || [kg∙x<sup>-1</sup>] || Tab. 5; Fig. 5 | ||
|- | |- | ||
| cell-mass concentration || [[ | | cell-mass concentration || [[Concentration]] || ''C''<sub>''m''<sub>ce</sub></sub> || [kg∙L<sup>-1</sup>] || ''see'' ''C''<sub>''m''<sub>s</sub></sub>: Tab. 4; ''C''<sub>''m''<sub>ce</sub></sub> = ''m''<sub>ce</sub>∙''V''<sup>-1</sup> | ||
|- | |- | ||
| cell-count concentration || [[ | | cell-count concentration || [[Concentration]] || ''C''<sub>ce</sub> || [x∙L<sup>-1</sup>] || Tab. 4; ''C''<sub>ce</sub> = ''N''<sub>ce</sub>∙''V''<sup>-1</sup> | ||
|- | |- | ||
| cell viability index || [[ | | cell viability index || [[Cell viability]] || ''VI'' || - || ''VI'' = ''N''<sub>vce</sub>∙''N''<sub>ce</sub><sup>-1</sup> = 1 - ''N''<sub>dce</sub>∙''N''<sub>ce</sub><sup>-1</sup> | ||
|- | |- | ||
| charge number of entity B || [[ | | charge number of entity B || [[Charge number]] || ''z''<sub>B</sub> || 1 || Tab. 6; ''z''<sub>O<sub>2</sub></sub> = 4 [[[Cohen 2008 IUPAC Green Book |24]]] | ||
|- | |- | ||
| Complexes I to IV || [[Complex I]] || CI to CIV || - || respiratory ET Complexes are redox proton pumps; Fig. 1B; F<sub>1</sub>F<sub>O</sub>-ATPase is not a redox proton pump of the ETS, hence the term CV is not recommended | | Complexes I to IV || [[Complex I]] || CI to CIV || - || respiratory ET Complexes are redox proton pumps; Fig. 1B; F<sub>1</sub>F<sub>O</sub>-ATPase is not a redox proton pump of the ETS, hence the term CV is not recommended | ||
|- | |- | ||
| concentration of X, count || [[ | | concentration of X, count || [[Concentration]] || ''C<sub>X</sub>'' = ''N<sub>X</sub>''∙''V''<sup>-1</sup> || [x∙L<sup>-1</sup>] || Tab. 4 (number concentration [[[Cohen 2008 IUPAC Green Book |24]]]) | ||
|- | |- | ||
| concentration of B, amount || [[ | | concentration of B, amount || [[Concentration]] || ''c''<sub>B</sub> = ''N''<sub>B</sub>∙''V''<sup>-1</sup> || [mol∙L<sup>-1</sup>] || SI: amount of substance concentration [[[Cohen 2008 IUPAC Green Book |24]]] | ||
|- | |- | ||
| concentration of O2, amount || [[ | | concentration of O2, amount || [[Concentration]] || ''c''<sub>O<sub>2</sub></sub> = ''n''<sub>O<sub>2</sub></sub>∙''V''<sup>-1</sup> || [mol∙L<sup>-1</sup>] || Box 2; [O<sub>2</sub>] | ||
|- | |- | ||
| count format || [[ | | count format || [[Format]] || <u>''N''</u> || [x] || Tab. 4, 5; Fig. 5 | ||
|- | |- | ||
| count of ''X'' || [[ | | count of ''X'' || [[Count]] || ''N<sub>X</sub>'' || [x] || SI; ''see'' number of entities ''X'' | ||
|- | |- | ||
| coupling control state || [[ | | coupling control state || [[Coupling control state]] || CCS || - || Section 2.4.1 | ||
|- | |- | ||
| dead cells || [[ | | dead cells || [[Cell viability]] || dce || - || Tab. 5 | ||
|- | |- | ||
| electrical format || [[ | | electrical format || [[Format]] || <u>''e''</u> || [C] || Tab. 6 | ||
|- | |- | ||
| electron transfer, state || [[ | | electron transfer, state || [[Electron transfer-pathway]] || ET || - || Tab. 1; Fig. 2B, 4 (State 3u) | ||
|- | |- | ||
| electron transfer system || [[ | | electron transfer system || [[Electron transfer-pathway]] || ETS || - || Fig. 2B, 4 (electron transport chain) | ||
|- | |- | ||
| entity || [[ | | entity || [[Entity]] || ''X'' || [x] || single countable object; Tab. 4 | ||
|- | |- | ||
| ET-capacity || [[ET-capacity]] || ''E'' || ''varies'' || rate; Tab. 1; Fig. 2 | | ET-capacity || [[ET-capacity]] || ''E'' || ''varies'' || rate; Tab. 1; Fig. 2 | ||
|- | |- | ||
| ET-excess capacity || [[ET- | | ET-excess capacity || [[ET-capacity]] || ''E-P'' || ''varies'' || Fig. 2 | ||
|- | |- | ||
| flow, for O<sub>2</sub> || [[ | | flow, for O<sub>2</sub> || [[Flow]] || ''I''<sub>O<sub>2</sub></sub> || [mol∙s<sup>-1</sup>] || system-related extensive quantity; Fig. 5 | ||
|- | |- | ||
| flux, for O2 || [[ | | flux, for O2 || [[Flux]] || ''J''<sub>O<sub>2</sub></sub> || ''varies'' || size-specific quantity; Fig. 5 | ||
|- | |- | ||
| inorganic phosphate || [[ | | inorganic phosphate || [[Phosphate]] || P<sub>i</sub> || - || Fig. 1C | ||
|- | |- | ||
| inorganic phosphate carrier || [[ | | inorganic phosphate carrier || [[Phosphate carrier]] || PiC || - || Fig. 1C | ||
|- | |- | ||
| isolated mitochondria || [[ | | isolated mitochondria || [[Isolated mitochondria]] || imt || - || Tab. 5 | ||
|- | |- | ||
| living cells || [[ | | living cells || [[Living cells]] || ce || - || Tab. 5 (intact cells) | ||
|- | |- | ||
| LEAK-state || [[LEAK-state]] || LEAK || - || Tab. 1; Fig. 2 (compare State 4) | | LEAK-state || [[LEAK-state]] || LEAK || - || Tab. 1; Fig. 2 (compare State 4) | ||
Line 83: | Line 83: | ||
| LEAK-respiration || [[LEAK-respiration]] || ''L'' || ''varies'' || rate; Tab. 1; Fig. 2 | | LEAK-respiration || [[LEAK-respiration]] || ''L'' || ''varies'' || rate; Tab. 1; Fig. 2 | ||
|- | |- | ||
| mass concentration of sample s || [[ | | mass concentration of sample s || [[Concentration]] || ''C<sub>m''<sub>s</sub></sub> || [kg∙L<sup>-1</sup>] || Tab. 4 | ||
|- | |- | ||
| mass format || [[ | | mass format || [[Format]] || <u>''m''</u> || [kg] || Tab. 4 | ||
|- | |- | ||
| mass of diluted sample || [[ | | mass of diluted sample || [[Mass]] || ''m''<sub>s</sub> || [kg] || SI: mass of pure sample ''m''<sub>S</sub> | ||
|- | |- | ||
| mass per single object || [[ | | mass per single object || [[Mass]] || ''M<sub>N<sub>X</sub></sub>'' || [kg∙x1] || Fig. 5; Tab. 4; SI: m(X); compare molar mass ''M''(''X'') | ||
|- | |- | ||
| mass, dry mass || [[ | | mass, dry mass || [[Mass]] || ''m''<sub>d</sub> ||[kg] || Fig. 5 (dry weight) | ||
|- | |- | ||
| mass, wet mass || [[ | | mass, wet mass || [[Mass]] || ''m''<sub>w</sub> || [kg] || Fig. 5 (wet weight) | ||
|- | |- | ||
| MITOCARTA || [https://www.broadinstitute.org/scientific-community/science/programs/metabolic-disease-program/publications/mitocarta/mitocarta-in-0 MITOCARTA] || || || | | MITOCARTA || [https://www.broadinstitute.org/scientific-community/science/programs/metabolic-disease-program/publications/mitocarta/mitocarta-in-0 MITOCARTA] || || || | ||
Line 99: | Line 99: | ||
| MitoPedia || [[MitoPedia]] || || || | | MitoPedia || [[MitoPedia]] || || || | ||
|- | |- | ||
| mitochondria or mitochondrial || [[ | | mitochondria or mitochondrial || [[Mitochondria]] || mt || - || Box 1 | ||
|- | |- | ||
| mitochondrial DNA || [[ | | mitochondrial DNA || [[Mitochondria]] || mtDNA || - || Box 1 | ||
|- | |- | ||
| mitochondrial concentration || [[ | | mitochondrial concentration || [[Concentration]] || ''C<sub>mtE</sub>'' = ''mtE''∙''V''<sup>-1</sup> || [mtEU∙L<sup>-1</sup>] || Tab. 4 | ||
|- | |- | ||
| mitochondrial content || [[ | | mitochondrial content || [[Mitochondria]] || ''mtE<sub>N<sub>X</sub></sub>'' || [mtEU∙x<sup>-1</sup>] || ''mtE<sub>N<sub>X</sub></sub>'' = ''mtE''∙''N<sub>X</sub>''<sup>-1</sup>; Tab. 4 | ||
|- | |- | ||
| mitochondrial density || [[ | | mitochondrial density || [[Density]] || ''D<sub>mtE</sub>''=''mtE''∙''m''<sub>s</sub><sup>-1</sup> || [mtEU∙kg<sup>-1</sup>] || tissue-mass specific mt-density; Tab. 4 | ||
|- | |- | ||
| mitochondrial elementary marker || [[ | | mitochondrial elementary marker || [[Mitochondria]] || ''mtE'' || [mtEU] || quantity of mt-marker; Tab. 4 | ||
|- | |- | ||
| mitochondrial elementary unit || [[ | | mitochondrial elementary unit || [[Mitochondria]] || mtEU || ''varies'' || specific units for mt-marker; Tab. 4 | ||
|- | |- | ||
| mitochondrial inner membrane || [[ | | mitochondrial inner membrane || [[Mitochondrial inner membrane]] || mtIM || - || Fig. 1; Box 1 (MIM) | ||
|- | |- | ||
| mitochondrial outer membrane || [[ | | mitochondrial outer membrane || [[Mitochondrial outer membrane]] || mtOM || - || Fig. 1; Box 1 (MIM) | ||
|- | |- | ||
| mitochondrial recovery || [[ | | mitochondrial recovery || [[Mitochondrial recovery]] || ''Y<sub>mtE</sub>'' || 1 || fraction of ''mtE'' recovered from the tissue sample in imt-stock | ||
|- | |- | ||
| mitochondrial yield || [[ | | mitochondrial yield || [[Mitochondrial yield]] || ''Y<sub>mtE</sub>''/''m''<sub>s</sub> || [mtEU∙kg<sup>-1</sup>] || mt-yield in imt-stock per mass of tissue sample; ''Y<sub>mtE</sub>''/''m''<sub>s</sub>=''Y<sub>mtE</sub>''∙''D<sub>mtE</sub>'' | ||
|- | |- | ||
| molar format || [[ | | molar format || [[Format]] || <u>''n''</u> || [mol] || Tab. 6 | ||
|- | |- | ||
| molar mass || [[ | | molar mass || [[Molar mass]] || ''M''<sub>B</sub> || [kg∙mol<sup>-1</sup>] || ''compare'' ''M<sub>N''<sub>B</sub></sub> [kg∙x<sup>-1</sup>]; SI ''M''(''X'') | ||
|- | |- | ||
| negative || [[ | | negative || [[Protonmotive force]] || neg || - || Fig. 4 | ||
|- | |- | ||
| number of cells || [[ | | number of cells || [[Count]] || ''N''<sub>ce</sub> || [x] || total cell count of living cells, ''N''<sub>ce</sub> = ''N''<sub>vce</sub> + ''N''<sub>dce</sub>; Tab. 4, 5 | ||
|- | |- | ||
| number of dead cells || [[ | | number of dead cells || [[Cell viability]] || ''N''<sub>dce</sub> || [x] || non-viable cell count, loss of plasma membrane barrier function; Tab. 5 | ||
|- | |- | ||
| number of entities B || [[ | | number of entities B || [[Count]] || ''N''<sub>B</sub> || [x] || Tab. 4 [[[Cohen 2008 IUPAC Green Book |24]]] | ||
|- | |- | ||
| number of entities ''X''; count || [[ | | number of entities ''X''; count || [[Count]] || ''N<sub>X</sub>'' || [x] || ‘count’ is an SI quantity [11], but the counting unit [x] is not in the SI [95]; Tab. 4; Fig. 5 | ||
|- | |- | ||
| number of viable cells || [[viability]] || ''N''<sub>vce</sub> || [x] || viable cell count, intact plasma membrane barrier function; Tab. 5 | | number of viable cells || [[Cell viability]] || ''N''<sub>vce</sub> || [x] || viable cell count, intact plasma membrane barrier function; Tab. 5 | ||
|- | |- | ||
| organisms || [[ | | organisms || [[Organism]] || org || - || Tab. 5 | ||
|- | |- | ||
| oxidative phosphorylation || [[ | | oxidative phosphorylation || [[Oxidative phosphorylation]] || OXPHOS || - || Tab. 1 | ||
|- | |- | ||
| OXPHOS-state || [[OXPHOS-state]] || OXPHOS || - || Tab. 1; Fig. 2; OXPHOS-state distinguished from the process OXPHOS (State 3 at kinetically-saturating [ADP] and [P<sub>i</sub>]) | | OXPHOS-state || [[OXPHOS-state]] || OXPHOS || - || Tab. 1; Fig. 2; OXPHOS-state distinguished from the process OXPHOS (State 3 at kinetically-saturating [ADP] and [P<sub>i</sub>]) | ||
Line 145: | Line 145: | ||
| OXPHOS-capacity || [[OXPHOS-capacity]] || ''P'' || ''varies'' || rate; Tab. 1; Fig. 2 | | OXPHOS-capacity || [[OXPHOS-capacity]] || ''P'' || ''varies'' || rate; Tab. 1; Fig. 2 | ||
|- | |- | ||
| oxygen concentration || [[concentration]] || ''c''<sub>O<sub>2</sub></sub> = ''n''<sub>O<sub>2</sub></sub>∙''V''<sup>-1</sup> || [mol∙L<sup>-1</sup>] || [O<sub>2</sub>]; Section 3.2 | | oxygen concentration || [[Oxygen concentration]] || ''c''<sub>O<sub>2</sub></sub> = ''n''<sub>O<sub>2</sub></sub>∙''V''<sup>-1</sup> || [mol∙L<sup>-1</sup>] || [O<sub>2</sub>]; Section 3.2 | ||
|- | |- | ||
| oxygen flux, in reaction r || [[ | | oxygen flux, in reaction r || [[Oxygen flux]] || ''J''<sub>rO<sub>2</sub></sub> || ''varies'' || Overview | ||
|- | |- | ||
| pathway control state || [[ | | pathway control state || [[Pathway control state]] || PCS || - || Section 2.2 | ||
|- | |- | ||
| permeability transition || [[ | | permeability transition || [[Permeability transition]] || mtPT || - || Fig. 3; Section 2.4.3 (MPT) | ||
|- | |- | ||
| permeabilized cells || [[ | | permeabilized cells || [[Permeabilized cells]] || pce || - || experimental permeabilization of plasma membrane; Tab. 5 | ||
|- | |- | ||
| permeabilized muscle fibers || [[ | | permeabilized muscle fibers || [[Permeabilized muscle fibers]] || pfi || - || Tab. 5 | ||
|- | |- | ||
| permeabilized tissue || [[ | | permeabilized tissue || [[Permeabilized tissue]] || pti || - || Tab. 5 | ||
|- | |- | ||
| phosphorylation of ADP to ATP || [[phosphorylation]] || P» || - || Tab. 1, 2; Fig. 1, 4 | | phosphorylation of ADP to ATP || [[Oxidative phosphorylation]] || P» || - || Tab. 1, 2; Fig. 1, 4 | ||
|- | |- | ||
| P»/O2 ratio || [[phosphorylation]] || P»/O2 || 1 || mechanistic YP»/O2, calculated from pump stoichiometries; Fig. 1c | | P»/O2 ratio || [[Oxidative phosphorylation]] || P»/O2 || 1 || mechanistic YP»/O2, calculated from pump stoichiometries; Fig. 1c | ||
|- | |- | ||
| positive || [[ | | positive || positive || [[Protonmotive force]] || - || Fig. 4 | ||
|- | |- | ||
| proton in the neg compartment || [[ | | proton in the neg compartment || [[Protonmotive force]] || H<sup>+</sup><sub>neg</sub> || [x] || Fig. 4 | ||
|- | |- | ||
| proton in the pos compartment || [[proton in the positive compartment]] || H<sup>+</sup><sub>pos</sub> || [x] || Fig. 4 | | proton in the pos compartment || [[proton in the positive compartment]] || H<sup>+</sup><sub>pos</sub> || [x] || Fig. 4 | ||
Line 177: | Line 177: | ||
| rate in OXPHOS-state || [[OXPHOS]] || ''P'' || ''varies'' || OXPHOS-capacity; Tab.1; Fig. 2, 4 | | rate in OXPHOS-state || [[OXPHOS]] || ''P'' || ''varies'' || OXPHOS-capacity; Tab.1; Fig. 2, 4 | ||
|- | |- | ||
| rate in ROX state || [[ | | rate in ROX state || [[Residual oxygen consumption]] || ''Rox'' || ''varies'' || Overview; Tab. 1 | ||
|- | |- | ||
| residual oxygen consumption || [[ | | residual oxygen consumption || [[Residual oxygen consumption]] || ROX; ''Rox'' || - || state ROX; rate Rox; Tab. 1 | ||
|- | |- | ||
| respiration || [[ | | respiration || [[Respiration]] || ''J''<sub>rO<sub>2</sub></sub> || ''varies'' || rate of reaction r; Overview | ||
|- | |- | ||
| respiratory supercomplex || [[ | | respiratory supercomplex || [[Supercomplex]] || SCI<sub>''n''</sub>III<sub>''n''</sub>IV<sub>''n''</sub> || - || supramolecular assemblies with variable copy numbers (n) of CI, CIII and CIV; Box 1 | ||
|- | |- | ||
| sample || [[ | | sample || [[Sample]] || s || - || diluted sample; Tab. 4, 5 | ||
|- | |- | ||
| substrate concentration at half-maximal rate || [[ | | substrate concentration at half-maximal rate || [[Concentration]] || ''c''<sub>50</sub> || [mol∙L<sup>-1</sup>] || Section 2.1.2 | ||
|- | |- | ||
| substrate-uncoupler-inhibitor-titration || [[ | | substrate-uncoupler-inhibitor-titration || [[Substrate-uncoupler-inhibitor-titration]] || SUIT || - || Section 2.2 | ||
|- | |- | ||
| tissue homogenate || [[ | | tissue homogenate || [[Tissue homogenate]] || thom || - || Tab. 5 | ||
|- | |- | ||
| viable cells || [[ | | viable cells || [[Viable cells]] || vce || - || Tab. 5 | ||
|- | |- | ||
| volume of chamber || [[ | | volume of chamber || [[Volume]] || ''V'' || [L] || Tab. 4, 7; Fig. 5 | ||
|- | |- | ||
| volume format || [[ | | volume format || [[Format]] || <u>''V''</u> || [L] || Tab. 6 | ||
|- | |- | ||
| volume of sample s || [[ | | volume of sample s || [[Volume]] || ''V''<sub>s</sub> || [L] || Tab. 5; Fig. 5 | ||
|} | |} | ||
Revision as of 07:48, 26 May 2020
Table 8. Terms, symbols, and units. SI base units are used, except for the liter [L = dm3]. SI refers to ref. [11].
Term | Link to MitoPedia term | Symbol | Unit | Links and comments |
---|---|---|---|---|
alternative quinol oxidase] | Alternative oxidase | AOX | - | Fig. 1B |
adenosine monophosphate | AMP | AMP | - | 2 ADP ↔ ATP+AMP |
adenosine diphosphate | ADP | ADP | - | Tab. 1; Fig. 1, 2, 5 |
adenosine triphosphate | ATP | ATP | - | Fig. 2, 5 |
adenylates | Adenylates | AMP, ADP, ATP | - | Section 2.5.1 |
amount of substance X | Amount | nX or n(X) | [mol] | SI |
ATP yield per O2 | ATP yield | YP»/O2 | 1 | P»/O2 ratio measured in any respiratory state |
catabolic reaction | Respiration | k | - | Fig. 1, 3 |
catabolic rate of respiration | Respiration | JkO2; IkO2 | varies | Fig. 1, 3; see flux J and flow I |
cell count | Count | Nce | [x] | Tab. 4; Fig. 5; see number of cells |
cell mass | Mass | mce | [kg] | Tab. 5; Fig. 5 |
cell mass, mass per cell | Mass | MNce | [kg∙x-1] | Tab. 5; Fig. 5 |
cell-mass concentration | Concentration | Cmce | [kg∙L-1] | see Cms: Tab. 4; Cmce = mce∙V-1 |
cell-count concentration | Concentration | Cce | [x∙L-1] | Tab. 4; Cce = Nce∙V-1 |
cell viability index | Cell viability | VI | - | VI = Nvce∙Nce-1 = 1 - Ndce∙Nce-1 |
charge number of entity B | Charge number | zB | 1 | Tab. 6; zO2 = 4 [[[Cohen 2008 IUPAC Green Book |24]]] |
Complexes I to IV | Complex I | CI to CIV | - | respiratory ET Complexes are redox proton pumps; Fig. 1B; F1FO-ATPase is not a redox proton pump of the ETS, hence the term CV is not recommended |
concentration of X, count | Concentration | CX = NX∙V-1 | [x∙L-1] | Tab. 4 (number concentration [[[Cohen 2008 IUPAC Green Book |24]]]) |
concentration of B, amount | Concentration | cB = NB∙V-1 | [mol∙L-1] | SI: amount of substance concentration [[[Cohen 2008 IUPAC Green Book |24]]] |
concentration of O2, amount | Concentration | cO2 = nO2∙V-1 | [mol∙L-1] | Box 2; [O2] |
count format | Format | N | [x] | Tab. 4, 5; Fig. 5 |
count of X | Count | NX | [x] | SI; see number of entities X |
coupling control state | Coupling control state | CCS | - | Section 2.4.1 |
dead cells | Cell viability | dce | - | Tab. 5 |
electrical format | Format | e | [C] | Tab. 6 |
electron transfer, state | Electron transfer-pathway | ET | - | Tab. 1; Fig. 2B, 4 (State 3u) |
electron transfer system | Electron transfer-pathway | ETS | - | Fig. 2B, 4 (electron transport chain) |
entity | Entity | X | [x] | single countable object; Tab. 4 |
ET-capacity | ET-capacity | E | varies | rate; Tab. 1; Fig. 2 |
ET-excess capacity | ET-capacity | E-P | varies | Fig. 2 |
flow, for O2 | Flow | IO2 | [mol∙s-1] | system-related extensive quantity; Fig. 5 |
flux, for O2 | Flux | JO2 | varies | size-specific quantity; Fig. 5 |
inorganic phosphate | Phosphate | Pi | - | Fig. 1C |
inorganic phosphate carrier | Phosphate carrier | PiC | - | Fig. 1C |
isolated mitochondria | Isolated mitochondria | imt | - | Tab. 5 |
living cells | Living cells | ce | - | Tab. 5 (intact cells) |
LEAK-state | LEAK-state | LEAK | - | Tab. 1; Fig. 2 (compare State 4) |
LEAK-respiration | LEAK-respiration | L | varies | rate; Tab. 1; Fig. 2 |
mass concentration of sample s | Concentration | Cms | [kg∙L-1] | Tab. 4 |
mass format | Format | m | [kg] | Tab. 4 |
mass of diluted sample | Mass | ms | [kg] | SI: mass of pure sample mS |
mass per single object | Mass | MNX | [kg∙x1] | Fig. 5; Tab. 4; SI: m(X); compare molar mass M(X) |
mass, dry mass | Mass | md | [kg] | Fig. 5 (dry weight) |
mass, wet mass | Mass | mw | [kg] | Fig. 5 (wet weight) |
MITOCARTA | MITOCARTA | |||
MitoPedia | MitoPedia | |||
mitochondria or mitochondrial | Mitochondria | mt | - | Box 1 |
mitochondrial DNA | Mitochondria | mtDNA | - | Box 1 |
mitochondrial concentration | Concentration | CmtE = mtE∙V-1 | [mtEU∙L-1] | Tab. 4 |
mitochondrial content | Mitochondria | mtENX | [mtEU∙x-1] | mtENX = mtE∙NX-1; Tab. 4 |
mitochondrial density | Density | DmtE=mtE∙ms-1 | [mtEU∙kg-1] | tissue-mass specific mt-density; Tab. 4 |
mitochondrial elementary marker | Mitochondria | mtE | [mtEU] | quantity of mt-marker; Tab. 4 |
mitochondrial elementary unit | Mitochondria | mtEU | varies | specific units for mt-marker; Tab. 4 |
mitochondrial inner membrane | Mitochondrial inner membrane | mtIM | - | Fig. 1; Box 1 (MIM) |
mitochondrial outer membrane | Mitochondrial outer membrane | mtOM | - | Fig. 1; Box 1 (MIM) |
mitochondrial recovery | Mitochondrial recovery | YmtE | 1 | fraction of mtE recovered from the tissue sample in imt-stock |
mitochondrial yield | Mitochondrial yield | YmtE/ms | [mtEU∙kg-1] | mt-yield in imt-stock per mass of tissue sample; YmtE/ms=YmtE∙DmtE |
molar format | Format | n | [mol] | Tab. 6 |
molar mass | Molar mass | MB | [kg∙mol-1] | compare MNB [kg∙x-1]; SI M(X) |
negative | Protonmotive force | neg | - | Fig. 4 |
number of cells | Count | Nce | [x] | total cell count of living cells, Nce = Nvce + Ndce; Tab. 4, 5 |
number of dead cells | Cell viability | Ndce | [x] | non-viable cell count, loss of plasma membrane barrier function; Tab. 5 |
number of entities B | Count | NB | [x] | Tab. 4 [[[Cohen 2008 IUPAC Green Book |24]]] |
number of entities X; count | Count | NX | [x] | ‘count’ is an SI quantity [11], but the counting unit [x] is not in the SI [95]; Tab. 4; Fig. 5 |
number of viable cells | Cell viability | Nvce | [x] | viable cell count, intact plasma membrane barrier function; Tab. 5 |
organisms | Organism | org | - | Tab. 5 |
oxidative phosphorylation | Oxidative phosphorylation | OXPHOS | - | Tab. 1 |
OXPHOS-state | OXPHOS-state | OXPHOS | - | Tab. 1; Fig. 2; OXPHOS-state distinguished from the process OXPHOS (State 3 at kinetically-saturating [ADP] and [Pi]) |
OXPHOS-capacity | OXPHOS-capacity | P | varies | rate; Tab. 1; Fig. 2 |
oxygen concentration | Oxygen concentration | cO2 = nO2∙V-1 | [mol∙L-1] | [O2]; Section 3.2 |
oxygen flux, in reaction r | Oxygen flux | JrO2 | varies | Overview |
pathway control state | Pathway control state | PCS | - | Section 2.2 |
permeability transition | Permeability transition | mtPT | - | Fig. 3; Section 2.4.3 (MPT) |
permeabilized cells | Permeabilized cells | pce | - | experimental permeabilization of plasma membrane; Tab. 5 |
permeabilized muscle fibers | Permeabilized muscle fibers | pfi | - | Tab. 5 |
permeabilized tissue | Permeabilized tissue | pti | - | Tab. 5 |
phosphorylation of ADP to ATP | Oxidative phosphorylation | P» | - | Tab. 1, 2; Fig. 1, 4 |
P»/O2 ratio | Oxidative phosphorylation | P»/O2 | 1 | mechanistic YP»/O2, calculated from pump stoichiometries; Fig. 1c |
positive | positive | Protonmotive force | - | Fig. 4 |
proton in the neg compartment | Protonmotive force | H+neg | [x] | Fig. 4 |
proton in the pos compartment | proton in the positive compartment | H+pos | [x] | Fig. 4 |
protonmotive force | protonmotive force | pmF | [V] | Overview; Tab. 1; Fig 1a, 2, 4 |
rate in ET-state | ET | E | varies | ET-capacity; Tab. 1; Fig. 2, 4 |
rate in LEAK-state | LEAK | L | varies | Tab. 1: L(n), L(T), L(Omy); Fig. 2, 4 |
rate in OXPHOS-state | OXPHOS | P | varies | OXPHOS-capacity; Tab.1; Fig. 2, 4 |
rate in ROX state | Residual oxygen consumption | Rox | varies | Overview; Tab. 1 |
residual oxygen consumption | Residual oxygen consumption | ROX; Rox | - | state ROX; rate Rox; Tab. 1 |
respiration | Respiration | JrO2 | varies | rate of reaction r; Overview |
respiratory supercomplex | Supercomplex | SCInIIInIVn | - | supramolecular assemblies with variable copy numbers (n) of CI, CIII and CIV; Box 1 |
sample | Sample | s | - | diluted sample; Tab. 4, 5 |
substrate concentration at half-maximal rate | Concentration | c50 | [mol∙L-1] | Section 2.1.2 |
substrate-uncoupler-inhibitor-titration | Substrate-uncoupler-inhibitor-titration | SUIT | - | Section 2.2 |
tissue homogenate | Tissue homogenate | thom | - | Tab. 5 |
viable cells | Viable cells | vce | - | Tab. 5 |
volume of chamber | Volume | V | [L] | Tab. 4, 7; Fig. 5 |
volume format | Format | V | [L] | Tab. 6 |
volume of sample s | Volume | Vs | [L] | Tab. 5; Fig. 5 |
- Keywords—MitoPedia - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>